These life sciences jobs could triple. Inside the big effort to train workers.
Philadelphia cell and gene therapy, and gene editing companies are preparing to add more than 1,100 new employees per year for the next decade. The sector now employs about 4,900 workers in the region but that number is expected to grow to more than 11,274 jobs in just 10 years.
With such a clear sight on the projected growth and the workforce needs that the industry will have, the region is in an all-out race to grow a sustainable workforce… and the strategy is working.
Life Sciences Talent Pipeline Collaborative
Read the full article at: www.inquirer.com
Latest posts by Chris Frew (see all)
- Patient-Centric Approach to Clinical Trials Improves Outcomes for All Stakeholders - September 21, 2021
- Three New Members with Ties to Johns Hopkins Appointed to National Cancer Advisory Board by President Biden - September 21, 2021
- Philadelphia biopharm firm Context Therapeutics files plans for IPO - September 21, 2021
- Dr. Anthony Fauci & AGT’s Jeff Galvin Join ‘I AM BIO’ to Discuss Future of HIV Treatments - September 14, 2021
- Data Center Firm DataBridge Sites Expands into Philadelphia, Maryland, and Chicago | Business Wire - September 7, 2021